Discounted Tickets Available for Me2/Orchestra for Mental Health Awareness Month
Richard Edley
Dr. Richard Edley is the lead executive for RCPA and is responsible for all aspects of operations and direction for the association. His professional career began in 1988 and most recently he was president and CEO of PerformCare/Community Behavioral HealthCare Network of Pennsylvania, Inc., a national, full-service, behavioral health managed care organization.
Medicaid Matters: A Community Forum to Be Held April 21, With Panelists Including RCPA Honorary Board Member Jim Cook
This community-focused advocacy forum brings together experts and stakeholders to discuss the local impact of federal funding cuts to Medicaid, particularly on vulnerable populations and essential services.
The event will be moderated by Chip Minemyer, publisher of The Tribune-Democrat, and panelists will include RCPA Honorary Board Member Jim Cook, who serves as Executive Director of Cambria Residential Services.
The event will be held Monday, April 21, at 6:30 pm. You can view the flyer here for more details.
RCPA Member Children’s Crisis Treatment Center to Host Advocacy Event “Creating Cultures of Growth and Healing”
ANCOR Issues Statement in Response to Tragic Incident in Idaho
Disabilities Community ‘Concerned’ by Proposed Cuts, Changing Landscape: RCPA Capitol Day Event Highlighted, RCPA Members CIL and Step by Step, Inc. Quoted
National Council Issues Notice on Rescission of Certain COVID-19 Relief Funds
RCPA Member Vista Autism Services Awarded T-Mobile Hometown Grant to Enhance Learning Spaces for Students With Autism
Provider Roundtable on Integrating Psychedelic Therapies Into Healthcare to Be Held on April 1
Interested in learning more about how to integrate psychedelic therapy into your future services?
BrainFutures and the University of Berkley’s Collaborative for Economics of Psychedelics are hosting a “Provider Roundtable: Integrating Psychedelic Therapies into Healthcare” on April 1 at 12:00 pm EST/9:00 am PST!
The Roundtable will share findings from a new white paper on opportunities and challenges in scaling psychedelic therapy post-FDA approval. You can read the white paper here, and don’t forget to register for the Provider Roundtable to discuss solutions on April 1.
NatCon25 Early Bird Rates End Today, March 10!
RCPA Member KenCrest Board Names Aurora Kripa Its Next CEO
Prev